Impact of somatic mutations on response to lenalidomide in lower-risk non-del(5q) myelodysplastic syndromes patients
Impact of somatic mutations on response to lenalidomide in lower-risk non-del(5q) myelodysplastic syndromes patients / Santini V.; Fenaux P.; Giagounidis A.; Platzbecker U.; List A.F.; Haferlach T.; Zhong J.; Wu C.; Mavrommatis K.; Beach C.L.; MacBeth K.J.; Almeida A.. - In: LEUKEMIA. - ISSN 0887-6924. - ELETTRONICO. - (2020), pp. 0-0. [10.1038/s41375-020-0961-3]
Impact of somatic mutations on response to lenalidomide in lower-risk non-del(5q) myelodysplastic syndromes patients
Santini V.;
2020
Abstract
Impact of somatic mutations on response to lenalidomide in lower-risk non-del(5q) myelodysplastic syndromes patients
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
s41375-020-0961-3LEUKEMIA2020somatic mutations 005.pdf
accesso aperto
Descrizione: pdf articolo in toto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Open Access
Dimensione
507.87 kB
Formato
Adobe PDF
|
507.87 kB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
